Previously operating as a production site, LGP hopes to broaden the facility’s service offering by building out a sales and marketing division and empowering the facility to engage with EU and global markets.
The LGP Group plans to immediately focus on delivering products in Australia and Germany as it grows its portfolio of export destinations over time.
“At Little Green Pharma our mission is to develop and supply cannabis medicines to patients that improve their quality of life.
The acquisition accelerates our ability to provide medicinal cannabis to Danish, Australian, and other patients across Europe.
With this purchase, existing facility team members will have continuity of employment resulting in no job losses and LGP will become a significant employer in Odense.